The Global Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Drugs for Herpes Labialis (Oral Herpes) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Drugs for Herpes Labialis (Oral Herpes) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, production revenue, cost, sales revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Drugs for Herpes Labialis (Oral Herpes) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed... Research Beam Model: Research Beam Product ID: 366370 2800 USD New
Global Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Deep Market Research Report
 

Global Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Deep Market Research Report

Global Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Deep Market Research Report

Category : Pharmaceuticals
Published On : December  2015
Pages : 176

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
The Global Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Drugs for Herpes Labialis (Oral Herpes) industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Drugs for Herpes Labialis (Oral Herpes) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, production revenue, cost, sales revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Drugs for Herpes Labialis (Oral Herpes) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 241 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview 1
1.1 Definition and Specifications of Drugs for Herpes Labialis (Oral Herpes) 1
1.1.1 Definition of Drugs for Herpes Labialis (Oral Herpes) 1
1.1.2 Specifications of Drugs for Herpes Labialis (Oral Herpes) 2
1.2 Classification of Drugs for Herpes Labialis (Oral Herpes) 2
1.2.1 Valacyclovir 3
1.2.2 Aciclovir 4
1.2.3 Famciclovir 5
1.3 Applications of Drugs for Herpes Labialis (Oral Herpes) 7
1.3.1 External use 8
1.3.2 Oral 8
1.3.3 Injection 9
1.4 Industry Chain Structure of Drugs for Herpes Labialis (Oral Herpes) 10
1.5 Industry Regional Overview of Drugs for Herpes Labialis (Oral Herpes) 10
1.6 Industry Policy Analysis of Drugs for Herpes Labialis (Oral Herpes) 12
1.7 Industry News Analysis of Drugs for Herpes Labialis (Oral Herpes) 12
2 Manufacturing Cost Structure Analysis of Drugs for Herpes Labialis (Oral Herpes) 15
2.1 Raw Material Suppliers and Price Analysis of Drugs for Herpes Labialis (Oral Herpes) 15
2.2 Equipment Suppliers Analysis of Drugs for Herpes Labialis (Oral Herpes) 16
2.3 Labor Cost Analysis of Drugs for Herpes Labialis (Oral Herpes) 18
2.4 Manufacturing Cost Structure Analysis of Drugs for Herpes Labialis (Oral Herpes) 21
2.5 Other Costs Analysis of Drugs for Herpes Labialis (Oral Herpes) 21
2.6 Manufacturing Cost Structure Analysis of Drugs for Herpes Labialis (Oral Herpes) 21
2.7 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes) 22
3 Technical Data and Manufacturing Plants Analysis 23
3.1 Revenue and Commercial Production Date of Global Key Manufacturers in 2015 23
3.2 Manufacturing Plants Distribution of Global Key Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2015 24
3.3 R&D Status and Technology Source of Global Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015 24
3.4 Raw Materials Sources of Global Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015 26
4 Production Analysis of Drugs for Herpes Labialis (Oral Herpes) by Region, Type, and Application 27
4.1 Global Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 27
4.2 Global Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Type 2010-2015 31
4.3 Global Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Application 2010-2015 35
4.4 Global Different Product Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 38
4.5 America Cost, Revenue, Supply, Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 39
4.6 Europe Cost, Revenue, Supply, Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 40
4.7 Southeast Asia Cost, Revenue, Supply, Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 40
4.8 Western Pacific Cost, Revenue, Supply, Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 41
4.9 China Cost, Revenue, Supply, Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 42
5 Consumption Volume and Consumption Value Analysis of Drugs for Herpes Labialis (Oral Herpes) by Region 43
5.1 Global Consumption Value of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 43
5.2 Global Valacyclovir Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 47
5.3 Global Aciclovir Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 51
5.4 Global Famciclovir Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 55
6 Analysis of Drugs for Herpes Labialis (Oral Herpes) Production Revenue, Sales Revenue and Market Status 2010-2015 59
6.1 Production Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 59
6.2 Production Revenue Market Share Analysis of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 63
6.3 Sales Overview of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 70
6.4 Supply Revenue, Sales Revenue and Gap of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 71
6.5 Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 71
6.6 Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 72
7 Analysis of Drugs for Herpes Labialis (Oral Herpes) Industry Key Manufacturers 75
7.1 GSK 75
7.1.1 Company Profile 75
7.1.2 Product Information 76
7.1.3 Cost, Gross and Revenue 77
7.2 Novartis 79
7.2.1 Company Profile 79
7.2.2 Product Information 80
7.2.3 Cost, Gross and Revenue 81
7.3 Teva 82
7.3.1 Company Profile 82
7.3.2 Product Information 83
7.3.3 Cost, Gross and Revenue 86
7.4 Apotex 87
7.4.1 Company Profile 87
7.4.2 Product Information 88
7.4.3 Cost, Gross and Revenue 89
7.5 Cadila 91
7.5.1 Company Profile 91
7.5.2 Product Information 92
7.5.3 Cost, Gross and Revenue 92
7.6 MYLAN 94
7.6.1 Company Profile 94
7.6.2 Product Information 95
7.6.3 Cost, Gross and Revenue 96
7.7 HETERO 97
7.7.1 Company Profile 97
7.7.2 Product Information 98
7.7.3 Cost, Gross and Revenue 99
7.8 Beech Tree 100
7.8.1 Company Profile 100
7.8.2 Product Information 101
7.8.3 Cost, Gross and Revenue 102
7.9 Onxeo 103
7.9.1 Company Profile 103
7.9.2 Product Information 104
7.9.3 Cost, Gross and Revenue 105
7.10 Foamix 107
7.10.1 Company Profile 107
7.10.2 Product Information 108
7.10.3 Cost, Gross and Revenue 108
7.11 Roxane 110
7.11.1 Company Profile 110
7.11.2 Product Information 111
7.11.3 Cost, Gross and Revenue 112
7.12 Livzon 113
7.12.1 Company Profile 113
7.12.2 Product Information 114
7.12.3 Cost, Gross and Revenue 115
7.13 Luoxin 117
7.13.1 Company Profile 117
7.13.2 Product Information 118
7.13.3 Cost, Gross and Revenue 119
7.14 Med shine 120
7.14.1 Company Profile 120
7.14.2 Product Information 121
7.14.3 Cost, Gross and Revenue 121
7.15 Haiwang 123
7.15.1 Company Profile 123
7.15.2 Product Information 124
7.15.3 Cost, Gross and Revenue 124
7.16 Kelun Group 126
7.16.1 Company Profile 126
7.16.2 Product Information 127
7.16.3 Cost, Gross and Revenue 127
8 Supply and Sales, Gross Margin Analysis 129
8.1 Analysis of Gross Margin, Supply and Sales Revenue 129
8.1.1 Gross Margin Analysis 129
8.1.2 Production, Sales Analysis 130
8.2 Gross Margin Analysis 130
8.3 Global Different Product Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 131
8.4 Sales Revenue Analysis of Different Drugs for Herpes Labialis (Oral Herpes) Product Types 132
8.5 Gross Margin Analysis of Different Drugs for Herpes Labialis (Oral Herpes) Applications 132
9 Marketing Trader or Distributor Analysis of Drugs for Herpes Labialis (Oral Herpes) 133
9.1 Marketing Channels Status of Drugs for Herpes Labialis (Oral Herpes) 133
9.2 Traders or Distributors of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 134
9.3 Regional Import, Export Analysis of Drugs for Herpes Labialis (Oral Herpes) 134
10 Development Trend of Drugs for Herpes Labialis (Oral Herpes) Industry 2015-2021 136
10.1 Production Revenue Market Share Analysis of Drugs for Herpes Labialis (Oral Herpes) 2015-2021 136
10.2 Sales Revenue Overview of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 139
10.3 Supply, Sales, and Gap of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 140
10.4 Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 141
10.5 Cost, Revenue and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 141
11 Industry Chain Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 142
11.1 Raw Materials Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 142
11.2 Manufacturing Equipment Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 143
11.3 Major Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 144
11.4 Key Consumers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 147
11.5 Supply Chain Relationship Analysis of Drugs for Herpes Labialis (Oral Herpes) 149
12 Analysis of Drugs for Herpes Labialis (Oral Herpes) New Development 150
12.1 Mymetics 150
12.2 NanoViricides 151
13 Conclusion of the Global Drugs for Herpes Labialis (Oral Herpes) Industry 2015 Deep Market Research Report 154

List of Tables and Figures

Figure Picture of Drugs for Herpes Labialis (Oral Herpes) 1
Table Specifications of Drugs for Herpes Labialis (Oral Herpes) 2
Table Classification of Drugs for Herpes Labialis (Oral Herpes) 2
Figure Global Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2015 3
Figure Valacyclovir Picture 3
Figure Aciclovir Picture 4
Figure Famciclovir Picture 6
Figure Application Fields of Drugs for Herpes Labialis (Oral Herpes) Products 7
Figure 2015 Global Drugs for Herpes Labialis (Oral Herpes) Major Applications Sales Share 8
Figure External use Examples 8
Figure Oral Examples 9
Figure Injection Examples 9
Figure Industry Chain Structure of Drugs for Herpes Labialis (Oral Herpes) 10
Table Industry Regional Overview of Drugs for Herpes Labialis (Oral Herpes) 10
Figure Global Production Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2015 11
Table Industry Policy of Drugs for Herpes Labialis (Oral Herpes) 12
Table Industry News List of Drugs for Herpes Labialis (Oral Herpes) 12
Table Major Raw Materials Analysis of Drugs for Herpes Labialis (Oral Herpes) 15
Table Key Equipment Analysis of Drugs for Herpes Labialis (Oral Herpes) 16
Figure 2014 APAC Overview of Average Monthly Labor Cost 18
Figure 2014 Americas Overview of Average Monthly Labor Cost 19
Figure 2014 EMEA Overview of Average Monthly Labor Cost 19
Figure 2010-2015 USA Employment Cost Index (ECI) 20
Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNY/a) 20
Figure Annual Depreciation Rate of Equipment in 2010-2015 21
Table Manufacturing Cost Structure Analysis of Drugs for Herpes Labialis (Oral Herpes) in 2015 21
Figure Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes) 22
Table Revenue (M USD) and Commercial Production Date of Global Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015 23
Table Manufacturing Plants Distribution of Global Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015 24
Table R&D Status and Technology Source of Global Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015 24
Table Raw Materials Sources of Global Drugs for Herpes Labialis (Oral Herpes) Key Manufacturers in 2015 26
Table Global Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 (M USD) 27
Table Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 27
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2010 28
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2011 28
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2012 29
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2013 29
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2014 30
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2015 30
Table Global Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Type 2010-2015 (M USD) 31
Table Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type 2010-2015 31
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2010 32
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2011 32
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2012 33
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2013 33
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2014 34
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2015 34
Table Global Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Application 2010-2015 (M USD) 35
Table Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application 2010-2015 35
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application in 2010 35
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application in 2011 36
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application in 2012 36
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application in 2013 37
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application in 2014 37
Figure Global Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application in 2015 38
Figure Valacyclovir Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 38
Figure Aciclovir Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 38
Figure Famciclovir Production Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 39
Table America Revenue (M USD), Cost (M USD), and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 39
Table America Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 39
Table Europe Revenue (M USD), Cost (M USD), and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 40
Table Europe Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 40
Table Southeast Asia Revenue (M USD), Cost (M USD), and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 40
Table Southeast Asia Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 41
Table Western Pacific Revenue (M USD), Cost (M USD), and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 41
Table Western Pacific Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 41
Table China Revenue (M USD), Cost (M USD), and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 42
Table China Production Revenue, Import Revenue, Export Revenue and Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 42
Table Global Consumption Value of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 (M USD) 43
Table Global Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 43
Figure Global Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2010 44
Figure Global Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2011 44
Figure Global Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2012 45
Figure Global Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2013 45
Figure Global Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2014 46
Figure Global Consumption Value Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2015 46
Table Global Valacyclovir Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 (M USD) 47
Table Global Valacyclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 47
Figure Global Valacyclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2010 48
Figure Global Valacyclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2011 48
Figure Global Valacyclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2012 49
Figure Global Valacyclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2013 49
Figure Global Valacyclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2014 50
Figure Global Valacyclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2015 50
Table Global Aciclovir Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 (M USD) 51
Table Global Aciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 51
Figure Global Aciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2010 52
Figure Global Aciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2011 52
Figure Global Aciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2012 53
Figure Global Aciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2013 53
Figure Global Aciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2014 54
Figure Global Aciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2015 54
Table Global Famciclovir Sales Revenue of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 (M USD) 55
Table Global Famciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 55
Figure Global Famciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2010 56
Figure Global Famciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2011 56
Figure Global Famciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2012 57
Figure Global Famciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2013 57
Figure Global Famciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2014 58
Figure Global Famciclovir Sales Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region in 2015 58
Table Global and Major Manufacturers Production Revenue Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 59
Table Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers 2010-2015 60
Figure Global Revenue (M USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 61
Table China and Major Manufacturers Production Revenue of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 61
Table Production Revenue Market Share of China Major Manufacturers 2010-2015 61
Figure China Revenue (M USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 62
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2010 63
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2011 64
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2012 64
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2013 65
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2014 65
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2015 66
Figure China Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2010 66
Figure China Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2011 67
Figure China Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2012 67
Figure China Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2013 68
Figure China Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2014 68
Figure China Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2015 69
Figure Global Sales Revenue (M USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 70
Figure China Sales Revenue (M USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 70
Table Global Supply Revenue, Sales Revenue and Gap of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 71
Table China Supply Revenue, Sales Revenue and Gap of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 71
Table China Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 (M USD) 71
Table Gross Margin of Global Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers 2010-2015 72
Figure Gross Margin of Global Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers in 2014 73
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 73
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2010-2015 74
Table GSK Company Profile 75
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of GSK 76
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of GSK 2010-2015 77
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of GSK 2010-2015 78
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of GSK 2010-2015 78
Table Novartis Company Profile 79
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Novartis 80
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novartis 2010-2015 81
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Novartis 2010-2015 81
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Novartis 2010-2015 82
Table Teva Company Profile 82
Tabel Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Teva 83
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Teva 2010-2015 86
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Teva 2010-2015 86
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Teva 2010-2015 87
Table Apotex Company Profile 87
Table Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Apotex 88
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Apotex 2010-2015 89
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Apotex 2010-2015 90
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Apotex 2010-2015 90
Table Cadila Company Profile 91
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Cadila 92
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Cadila 2010-2015 92
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Cadila 2010-2015 93
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Cadila 2010-2015 93
Table MYLAN Company Profile 94
Table Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of MYLAN 95
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of MYLAN 2010-2015 96
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of MYLAN 2010-2015 96
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of MYLAN 2010-2015 97
Table HETERO Company Profile 97
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of HETERO 98
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of HETERO 2010-2015 99
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of HETERO 2010-2015 99
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of HETERO 2010-2015 100
Table Beech Tree Company Profile 100
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Beech Tree 101
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Beech Tree 2010-2015 102
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Beech Tree 2010-2015 102
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Beech Tree 2010-2015 103
Table Onxeo Company Profile 103
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Onxeo 104
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Onxeo 2010-2015 105
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Onxeo 2010-2015 106
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Onxeo 2010-2015 106
Table Foamix Company Profile 107
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Foamix 108
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Foamix 2010-2015 108
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Foamix 2010-2015 109
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Foamix 2010-2015 110
Table Roxane Company Profile 110
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Roxane 111
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Roxane 2010-2015 112
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Roxane 2010-2015 112
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Roxane 2010-2015 113
Table Livzon Company Profile 113
Table Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Livzon 114
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Livzon 2010-2015 115
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Livzon 2010-2015 116
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Livzon 2010-2015 116
Table Luoxin Company Profile 117
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Luoxin 118
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Luoxin 2010-2015 119
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Luoxin 2010-2015 119
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Luoxin 2010-2015 120
Table Med shine Company Profile 120
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Med shine 121
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Med shine 2010-2015 121
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Med shine 2010-2015 122
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Med shine 2010-2015 122
Table Haiwang Company Profile 123
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Haiwang 124
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Haiwang 2010-2015 124
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Haiwang 2010-2015 125
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Haiwang 2010-2015 125
Table Kelun Group Company Profile 126
Figure Drugs for Herpes Labialis (Oral Herpes) Product Picture and Specifications of Kelun Group 127
Table Drugs for Herpes Labialis (Oral Herpes) Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Kelun Group 2010-2015 127
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Growth Rate of Kelun Group 2010-2015 128
Figure Drugs for Herpes Labialis (Oral Herpes) Production Revenue (M USD) and Global Market Share of Kelun Group 2010-2015 128
Table Gross Margin of Global Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers 2010-2015 129
Table America Production Revenue and Sales Revenue Analysis (M USD) 130
Table Europe Production Revenue and Sales Revenue Analysis (M USD) 130
Table Southeast Asia Production Revenue and Sales Revenue Analysis (M USD) 130
Table Western Pacific Production Revenue and Sales Revenue Analysis (M USD) 130
Table Gross Margin of Global Regions 2010-2015 130
Figure Valacyclovir Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 131
Figure Aciclovir Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 131
Figure Famciclovir Production Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Region 2010-2015 131
Table Sales Revenue of Different Drugs for Herpes Labialis (Oral Herpes) Product Types (M USD) 132
Table Gross Margin of Different Drugs for Herpes Labialis (Oral Herpes) Applications 2010-2015 132
Figure Marketing Channels Analysis of Drugs for Herpes Labialis (Oral Herpes) 133
Table Traders or Distributors of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 134
Table Regional Import, Export of Drugs for Herpes Labialis (Oral Herpes) (M USD) 134
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2015 136
Figure Global Production Revenue Market Share of Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2021 137
Figure Production Revenue Market Share of China Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2015 137
Figure Production Revenue Market Share of China Major Drugs for Herpes Labialis (Oral Herpes) Manufacturers in 2021 138
Figure Global Sales Revenue (M USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 139
Figure China Sales Revenue (M USD) and Growth Rate of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 140
Table Global Supply, Sales and Gap of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 (M USD) 140
Table China Supply, Sales and Gap of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 (M USD) 140
Table China Production, Import, Export and Consumption of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 (M USD) 141
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 141
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Drugs for Herpes Labialis (Oral Herpes) 2016-2021 141
Table Major Raw Materials Analysis of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 142
Table Manufacturing Equipment Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 143
Table Major Suppliers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 144
Table Key Consumers of Drugs for Herpes Labialis (Oral Herpes) with Contact Information 147
Figure Supply Chain Relationship Analysis of Drugs for Herpes Labialis (Oral Herpes) 149
Table Mymetics Company Profile 150
Table Research Introduction of Mymetics 151
Table NanoViricides Company Profile 151
Table Research Introduction of NanoViricides 152


Enquiry Before Buy